Anaptysbio (ANAB) Other Working Capital Changes (2016 - 2026)
Anaptysbio (ANAB) reported Other Working Capital Changes of -$499000.0 for Q1 2026, down 8.01% on a YoY basis from -$542442.4 in Q1 2025, and down 175.69% quarter-over-quarter from -$181000.0 in Q4 2025.
Anaptysbio (ANAB) Other Working Capital Changes (2016 - 2026) Analysis & Trends
Anaptysbio has reported Other Working Capital Changes for 11 years, with the latest figure at -$499000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 8.01% year-over-year to -$499000.0; the trailing twelve-month figure through Mar 2026 stood at -$1.6 million (up 68.48% YoY), and the FY2025 full-year result was -$1.6 million, up 49.67% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$499000.0, down from -$181000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $4.1 million in Q2 2022, with the low at -$6.5 million in Q3 2022.
- Historically, Other Working Capital Changes has averaged -$497352.9 across 5 years, with a median of -$420000.0 in 2023.
- The largest YoY upside for Other Working Capital Changes was 3170.59% in 2024 against a maximum downside of 288.39% in 2024.
- Anaptysbio's Other Working Capital Changes stood at -$389000.0 in 2022, then retreated by 7.97% to -$420000.0 in 2023, then rose by 28.81% to -$299000.0 in 2024, then soared by 39.46% to -$181000.0 in 2025, then tumbled by 175.69% to -$499000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$499000.0 (Q1 2026), -$181000.0 (Q4 2025), and -$490000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Anaptysbio | 1.66 Bn | 1.38 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -499,000.00 |
| Mar 31, 2026 | -499,000.00 |
| Dec 31, 2025 | -181,000.00 |
| Dec 31, 2025 | -181,000.00 |
| Sep 30, 2025 | -490,000.00 |
| Sep 30, 2025 | -490,000.00 |
| Jun 30, 2025 | -479,000.00 |
| Jun 30, 2025 | -479,000.00 |
| Mar 31, 2025 | -462,000.00 |
| Mar 31, 2025 | -462,000.00 |
| Dec 31, 2024 | -299,000.00 |
| Dec 31, 2024 | -299,000.00 |
| Sep 30, 2024 | -2.04 Mn |
| Sep 30, 2024 | -2.04 Mn |
| Jun 30, 2024 | -2.43 Mn |
| Jun 30, 2024 | -2.43 Mn |
| Mar 31, 2024 | 1.57 Mn |
| Mar 31, 2024 | 1.57 Mn |
| Dec 31, 2023 | -420,000.00 |
| Dec 31, 2023 | -420,000.00 |